Structure-Activity Relationships for CYP4B1 Bioactivation of 4-Ipomeanol Congeners: Direct Correlation between Cytotoxicity and Trapped Reactive Intermediates

被引:10
|
作者
Kowalski, John P. [1 ]
McDonald, Matthew G. [1 ]
Whittington, Dale [1 ]
Guttman, Miklos [1 ]
Scian, Michele [1 ]
Girhard, Marco [2 ]
Hanenberg, Helmut [3 ]
Wiek, Constanze [4 ]
Rettie, Allan E. [1 ]
机构
[1] Univ Washington, Sch Pharm, Dept Med Chem, Seattle, WA 98105 USA
[2] Heinrich Heine Univ, Inst Biochem, D-40225 Dusseldorf, Germany
[3] Univ Duisburg Essen, Univ Childrens Hosp Essen, Dept Pediat 3, D-45122 Essen, Germany
[4] Heinrich Heine Univ, Dept Otorhinolaryngol & Head Neck Surg, D-40225 Dusseldorf, Germany
关键词
COVALENT BINDING; RABBIT CYP4B1; IN-VITRO; CYTOCHROME-P450; METABOLITES; CANCER; HEME; P450; CELL; IDENTIFICATION;
D O I
10.1021/acs.chemrestox.9b00330
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Cytochrome P450 4B1 (CYP4B1) has been explored as a candidate enzyme in suicide gene systems for its ability to bioactivate the natural product 4-ipomeanol (IPO) to a reactive species that causes cytotoxicity. However, metabolic limitations of IPO necessitate discovery of new "pro-toxicant" substrates for CYP4B1. In the present study, we examined a series of synthetically facile N-alkyl-3-furancarbox-amides for cytotoxicity in HepG2 cells expressing CYP4B1. This compound series maintains the furan warhead of IPO while replacing its alcohol group with alkyl chains of varying length (C1-C8). Compounds with C3-C6 carbon chain lengths showed similar potency to IPO (LD50 approximate to 5 mu M). Short chain analogs (<3 carbons) and long chain analogs (>6 carbons) exhibited reduced toxicity, resulting in a parabolic relationship between alkyl chain length and cytotoxicity. A similar parabolic relationship was observed between alkyl chain length and reactive intermediate formation upon trapping of the putative enedial as a stable pyrrole adduct in incubations with purified recombinant rabbit CYP4B1 and common physiological nucleophiles. These parabolic relationships reflect the lower affinity of shorter chain compounds for CYP4B1 and increased omega-hydroxylation of the longer chain compounds by the enzyme. Furthermore, modest time-dependent inhibition of CYP4B1 by N-pentyl-3-furancarboxamide was completely abolished when trapping agents were added, demonstrating escape of reactive intermediates from the enzyme after bioactivation. An insulated CYP4B1 active site may explain the rarely observed direct correlation between adduct formation and cell toxicity reported here.
引用
收藏
页码:2488 / 2498
页数:11
相关论文
共 50 条
  • [31] PROBING THE MECHANISM OF BIOACTIVATION OF MPTP TYPE ANALOGS BY MONOAMINE-OXIDASE B - STRUCTURE-ACTIVITY STUDIES ON SUBSTITUTED 4-PHENOXY-1-CYCLOPROPYL-1,2,3,6-TETRAHYDROPYRIDINES, 4-PHENYL-1-CYCLOPROPYL-1,2,3,6-TETRAHYDROPYRIDINES, AND 4-THIOPHENOXY-1-CYCLOPROPYL-1,2,3,6-TETRAHYDROPYRIDINES
    RIMOLDI, JM
    WANG, YX
    NIMKAR, SK
    KUTTAB, SH
    ANDERSON, AH
    BURCH, H
    CASTAGNOLI, N
    CHEMICAL RESEARCH IN TOXICOLOGY, 1995, 8 (05) : 703 - 710
  • [32] Structure-Activity Relationships of 6-Methyl-benzo[b]thiophene-2-carboxylic Acid (1-{(S)-1-Benzyl-4-[4-(tetrahydropyran-4-ylmethyl)piperazin-1-yl]butylcarbamoyl}cyclopentyl)amide, Potent Antagonist of the Neurokinin-2 Receptor
    Fattori, Daniela
    Porcelloni, Marina
    D'Andrea, Piero
    Catalioto, Rose-Marie
    Ettorre, Alessandro
    Giuliani, Sandro
    Marastoni, Elena
    Mauro, Sandro
    Meini, Stefania
    Rossi, Cristina
    Altamura, Maria
    Maggi, Carlo A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (10) : 4148 - 4165
  • [33] Structure-activity relationships of a series of novel (piperazinylbutyl)thiazolidinone antipsychotic agents related to 3-[4-[4-(6-Fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2,5,5-trimethyl-4-thiazolidinone maleate
    Hrib, NJ
    Jurcak, JG
    Bregna, DE
    Burgher, KL
    Hartman, HB
    Kafka, S
    Kerman, LL
    Kongsamut, S
    Roehr, JE
    Szewczak, MR
    WoodsKettelberger, AT
    Corbett, R
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (20) : 4044 - 4057
  • [34] Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 2: Structure-activity relationships (SAR) of the C3-phenyl moiety
    Fader, Lee D.
    Landry, Serge
    Goulet, Sylvie
    Morin, Sebastien
    Kawai, Stephen H.
    Bousquet, Yves
    Dion, Isabelle
    Hucke, Oliver
    Goudreau, Nathalie
    Lemke, Christopher T.
    Rancourt, Jean
    Bonneau, Pierre
    Titolo, Steve
    Amad, Ma'an
    Garneau, Michel
    Duan, Jianmin
    Mason, Stephen
    Simoneau, Bruno
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (11) : 3401 - 3405
  • [35] Synthesis and Structure-Activity Relationships of DCLK1 Kinase Inhibitors Based on a 5,11-Dihydro-6H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6-one Scaffold
    Ferguson, Fleur M.
    Liu, Yan
    Harshbarger, Wayne
    Huang, Ling
    Wang, Jinhua
    Deng, Xianming
    Capuzzi, Stephen J.
    Muratov, Eugene N.
    Tropsha, Alexander
    Muthuswamy, Senthil
    Westover, Kenneth D.
    Gray, Nathanael S.
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (14) : 7817 - 7826
  • [36] Structure-activity relationships of substituted 2,3,4,4a,5,10b-hexahydro-benz[h]isoquinoline-6(1H)-ones as 5-HT2C receptor antagonists
    Stadler, H
    Wichmann, J
    Sleight, AJ
    Bös, M
    CHIMIA, 2000, 54 (11) : 669 - 671
  • [37] Organic compounds based on 1-(prop-2-yn-1-ylamino)-2,3-dihydro-1H-indene-4-thiol as selective human monoamine oxidase B inhibitors. Quantitative analysis of structure-activity relationships and in-silico investigations
    El Alaouy, M. Ahfid
    El Bahi, S.
    Boutalaka, M.
    Ouabane, M.
    Sbai, A.
    Maghat, H.
    Bouachrine, M.
    Lakhlifi, T.
    MOROCCAN JOURNAL OF CHEMISTRY, 2023, 11 (03): : 802 - 817
  • [38] Synthesis and structure-activity relationships of pyrido[3,2-b] pyrazin-3(4H)-ones and pteridin-7(8H)-ones as corticotropin-releasing factor-1 receptor antagonists
    Dzierba, Carolyn D.
    Sielecki, Thais M.
    Arvanitis, Argyrios G.
    Galka, Amy
    Johnson, Tricia L.
    Takvorian, Amy G.
    Rafalski, Maria
    Kasireddy-Polam, Padmaja
    Vig, Shikha
    Dasgupta, Bireshwar
    Zhang, Ge
    Molski, Thaddeus F.
    Wong, Harvey
    Zaczek, Robert C.
    Lodge, Nicholas J.
    Combs, Andrew P.
    Gilligan, Paul J.
    Trainor, George L.
    Bronson, Joanne J.
    Macor, John E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (15) : 4986 - 4989
  • [39] Inhibitors of HCVNS5B polymerase:: Synthesis and structure-activity relationships of N-1-benzyl and N-1-[3-methylbutyl]-4-hydroxy-1,8-naphthyridon-3-yl benzothiadiazine analogs containing substituents on the aromatic ring
    Rockway, Todd W.
    Zhang, Rong
    Liu, Dachun
    Betebenner, David A.
    McDaniel, Keith F.
    Pratt, John K.
    Beno, David
    Montgomery, Debra
    Jiang, Wen W.
    Masse, Sherie
    Kati, Warren M.
    Middleton, Tim
    Molla, Akhteruzzaman
    Maring, Clarence J.
    Kempf, Dale J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (14) : 3833 - 3838
  • [40] Novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonists: Synthesis and structure-activity relationships of 6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-pyrido[2,3-b]pyrazinedione and related compounds
    Ohmori, J
    Kubota, H
    ShimizuSasamata, M
    Okada, M
    Sakamoto, S
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (06) : 1331 - 1338